NCT02059590View on ClinicalTrials.gov

A Study to Evaluate the Pharmacokinetics of BAL8728 After a Single Dose of Pyridinylmethyl-14C-Labeled Isavuconazonium Sulfate in Healthy Male Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

6

Participants

Timeline

Start Date

April 30, 2013

Primary Completion Date

April 30, 2013

Study Completion Date

April 30, 2013

Conditions
Pharmacokinetics of 14C-labeled Isavuconazonium SulfateHealthy Subjects
Interventions
DRUG

Pyridinylmethyl-14C-labeled isavuconazonium sulfate

Intravenous

Trial Locations (1)

53704

Covance, Madison

Sponsors
All Listed Sponsors
collaborator

Basilea Pharmaceutica International Ltd

INDUSTRY

lead

Astellas Pharma Global Development, Inc.

INDUSTRY

NCT02059590 - A Study to Evaluate the Pharmacokinetics of BAL8728 After a Single Dose of Pyridinylmethyl-14C-Labeled Isavuconazonium Sulfate in Healthy Male Subjects | Biotech Hunter | Biotech Hunter